Global Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Flu Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Flu Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Flu Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Flu Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 FLU VACCINE MARKET BY MANUFACTURERS
3.1 Global Flu Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Flu Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Flu Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Flu Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Flu Vaccine Manufacturers, Product Type & Application
3.7 Global Flu Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Flu Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
4 FLU VACCINE MARKET BY TYPE
4.1 Flu Vaccine Type Introduction
4.1.1 Trivalent Influenza Vaccine
4.1.2 Quadrivalent Influenza Vaccine
4.2 Global Flu Vaccine Sales by Type
4.2.1 Global Flu Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Flu Vaccine Sales by Type (2019-2030)
4.2.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Flu Vaccine Revenue by Type
4.3.1 Global Flu Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Flu Vaccine Revenue by Type (2019-2030)
4.3.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
5 FLU VACCINE MARKET BY APPLICATION
5.1 Flu Vaccine Application Introduction
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Sales by Application
5.2.1 Global Flu Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales by Application (2019-2030)
5.2.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Flu Vaccine Revenue by Application
5.3.1 Global Flu Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Flu Vaccine Revenue by Application (2019-2030)
5.3.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL FLU VACCINE SALES BY REGION
6.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Flu Vaccine Sales by Region (2019-2030)
6.2.1 Global Flu Vaccine Sales by Region (2019-2024)
6.2.2 Global Flu Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Flu Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Flu Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Flu Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL FLU VACCINE REVENUE BY REGION
7.1 Global Flu Vaccine Revenue by Region
7.1.1 Global Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Flu Vaccine Revenue by Region (2019-2024)
7.1.3 Global Flu Vaccine Revenue by Region (2025-2030)
7.1.4 Global Flu Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Flu Vaccine Revenue (2019-2030)
7.2.2 North America Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Flu Vaccine Revenue (2019-2030)
7.3.2 Europe Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Flu Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Flu Vaccine Revenue (2019-2030)
7.5.2 LAMEA Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Flu Vaccine Product Portfolio
8.2.5 CSL Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 GSK Flu Vaccine Product Portfolio
8.3.5 GSK Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Mylan Flu Vaccine Product Portfolio
8.4.5 Mylan Recent Developments
8.5 Hulan Bio
8.5.1 Hulan Bio Comapny Information
8.5.2 Hulan Bio Business Overview
8.5.3 Hulan Bio Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hulan Bio Flu Vaccine Product Portfolio
8.5.5 Hulan Bio Recent Developments
8.6 AstraZeneca
8.6.1 AstraZeneca Comapny Information
8.6.2 AstraZeneca Business Overview
8.6.3 AstraZeneca Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 AstraZeneca Flu Vaccine Product Portfolio
8.6.5 AstraZeneca Recent Developments
8.7 CCBIO
8.7.1 CCBIO Comapny Information
8.7.2 CCBIO Business Overview
8.7.3 CCBIO Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 CCBIO Flu Vaccine Product Portfolio
8.7.5 CCBIO Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Flu Vaccine Value Chain Analysis
9.1.1 Flu Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flu Vaccine Production Mode & Process
9.2 Flu Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flu Vaccine Distributors
9.2.3 Flu Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Flu Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Flu Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Flu Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Flu Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 FLU VACCINE MARKET BY MANUFACTURERS
3.1 Global Flu Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Flu Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Flu Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Flu Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Flu Vaccine Manufacturers, Product Type & Application
3.7 Global Flu Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Flu Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
4 FLU VACCINE MARKET BY TYPE
4.1 Flu Vaccine Type Introduction
4.1.1 Trivalent Influenza Vaccine
4.1.2 Quadrivalent Influenza Vaccine
4.2 Global Flu Vaccine Sales by Type
4.2.1 Global Flu Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Flu Vaccine Sales by Type (2019-2030)
4.2.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Flu Vaccine Revenue by Type
4.3.1 Global Flu Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Flu Vaccine Revenue by Type (2019-2030)
4.3.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
5 FLU VACCINE MARKET BY APPLICATION
5.1 Flu Vaccine Application Introduction
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Sales by Application
5.2.1 Global Flu Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales by Application (2019-2030)
5.2.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Flu Vaccine Revenue by Application
5.3.1 Global Flu Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Flu Vaccine Revenue by Application (2019-2030)
5.3.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL FLU VACCINE SALES BY REGION
6.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Flu Vaccine Sales by Region (2019-2030)
6.2.1 Global Flu Vaccine Sales by Region (2019-2024)
6.2.2 Global Flu Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Flu Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Flu Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Flu Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Flu Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL FLU VACCINE REVENUE BY REGION
7.1 Global Flu Vaccine Revenue by Region
7.1.1 Global Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Flu Vaccine Revenue by Region (2019-2024)
7.1.3 Global Flu Vaccine Revenue by Region (2025-2030)
7.1.4 Global Flu Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Flu Vaccine Revenue (2019-2030)
7.2.2 North America Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Flu Vaccine Revenue (2019-2030)
7.3.2 Europe Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Flu Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Flu Vaccine Revenue (2019-2030)
7.5.2 LAMEA Flu Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Flu Vaccine Product Portfolio
8.2.5 CSL Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 GSK Flu Vaccine Product Portfolio
8.3.5 GSK Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Mylan Flu Vaccine Product Portfolio
8.4.5 Mylan Recent Developments
8.5 Hulan Bio
8.5.1 Hulan Bio Comapny Information
8.5.2 Hulan Bio Business Overview
8.5.3 Hulan Bio Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hulan Bio Flu Vaccine Product Portfolio
8.5.5 Hulan Bio Recent Developments
8.6 AstraZeneca
8.6.1 AstraZeneca Comapny Information
8.6.2 AstraZeneca Business Overview
8.6.3 AstraZeneca Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 AstraZeneca Flu Vaccine Product Portfolio
8.6.5 AstraZeneca Recent Developments
8.7 CCBIO
8.7.1 CCBIO Comapny Information
8.7.2 CCBIO Business Overview
8.7.3 CCBIO Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 CCBIO Flu Vaccine Product Portfolio
8.7.5 CCBIO Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Flu Vaccine Value Chain Analysis
9.1.1 Flu Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flu Vaccine Production Mode & Process
9.2 Flu Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flu Vaccine Distributors
9.2.3 Flu Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
